Company / Total Assets
PTC Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.9B
FY2025
5-year range
$1.7B / $2.9B
FY2021-FY2025
Trend
+70.0%
vs FY2024
Sector context
#34 of 214
Health Care
What the data says
PTC Therapeutics, Inc.'s total assets of $2.9B is higher than 84% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $269M in FY2016 to $2.9B in FY2025.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Improved from $1.9B to $2.9B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 214This company $2.9B Sector average $7.5B
▼
-61.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, total assets increased 70.0% year-over-year.
- Ranks #34 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +70.0% |
| FY2024 | $1.7B | -10.1% |
| FY2023 | $1.9B | +11.1% |
| FY2022 | $1.7B | -12.0% |
| FY2021 | $1.9B | -12.2% |
| FY2020 | $2.2B | +36.0% |
| FY2019 | $1.6B | +45.1% |
| FY2018 | $1.1B | +185.8% |
| FY2017 | $391.7M | +45.4% |
| FY2016 | $269.3M | -26.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026